Cargando…

The role of tumor-associated macrophages in primary hepatocellular carcinoma and its related targeting therapy

Liver macrophages consist of ontogenically distinct populations termed Kupffer cells and monocyte-derived macrophages. Tumor-associated macrophages (TAMs) inhepatocellularcarcinoma (HCC) play a prominent role in tumormicroenvironment by presenting M1(induced by IFN γ along with LPS) and M2(induced b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Lu, He, Kang, Pan, Yixiao, Wang, Hai, Luo, Yi, Xia, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040428/ https://www.ncbi.nlm.nih.gov/pubmed/33859517 http://dx.doi.org/10.7150/ijms.56003

Ejemplares similares

Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes
por: Pan, Yixiao, et al.
Publicado: (2020)

Macrophage Polarization and Liver Ischemia-Reperfusion Injury
por: Wang, Hai, et al.
Publicado: (2021)

Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy
por: Zheng, Hongyu, et al.
Publicado: (2023)

Targeting Akt in Hepatocellular Carcinoma and Its Tumor Microenvironment
por: Mroweh, Mariam, et al.
Publicado: (2021)

The Role of Tumor Associated Macrophages in Hepatocellular Carcinoma
por: Huang, Yu, et al.
Publicado: (2021)

Pure Laparoscopic Living Donor Hepatectomy With/Without Fluorescence-Assisted Technology and Conventional Open Procedure: A Retrospective Study in Mainland China
por: He, Kang, et al.
Publicado: (2021)

Mechanisms of tumor-associated macrophages affecting the progression of hepatocellular carcinoma
por: Yuan, Yi, et al.
Publicado: (2023)

Tumor-associated macrophages modulate resistance to oxaliplatin via inducing autophagy in hepatocellular carcinoma
por: Fu, Xiu-Tao, et al.
Publicado: (2019)

Potential therapeutic targets in the tumor microenvironment of hepatocellular carcinoma: reversing the protumor effect of tumor-associated macrophages
por: Zhou, Jingyi, et al.
Publicado: (2021)

Tumor-Associated Macrophages in Hepatocellular Carcinoma: Friend or Foe?
por: Zhou, Dexi, et al.
Publicado: (2021)

Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
por: Agirre-Lizaso, Aloña, et al.
Publicado: (2023)

Macrophages and hepatocellular carcinoma
por: Tian, Zhiqiang, et al.
Publicado: (2019)

Analysis of microarrays of miR-34a and its identification of prospective target gene signature in hepatocellular carcinoma
por: Ren, Fang-Hui, et al.
Publicado: (2018)

Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
por: Arvanitakis, Konstantinos, et al.
Publicado: (2022)

MT4‐MMP in tumor‐associated macrophages is linked to hepatocellular carcinoma aggressiveness and recurrence
por: Qi, Feng, et al.
Publicado: (2020)

Hepatocellular Carcinoma Cell-Derived Exosomal miR-21-5p Induces Macrophage M2 Polarization by Targeting RhoB
por: Yu, Haiyang, et al.
Publicado: (2023)

Screening therapeutic targets of ribavirin in hepatocellular carcinoma
por: Xu, Chen, et al.
Publicado: (2018)

The tumor microenvironment of hepatocellular carcinoma and its targeting strategy by CAR-T cell immunotherapy
por: Guizhen, Zhang, et al.
Publicado: (2022)

CT-pathologic correlation in primary hepatocellular carcinoma: an implication for target delineation
por: Chen, Hai-yan, et al.
Publicado: (2013)

Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2014)

Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study
por: Zhang, Ning, et al.
Publicado: (2014)

H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
por: Yu, Sihang, et al.
Publicado: (2022)

Crosstalk between tumor-associated macrophages and neighboring cells in hepatocellular carcinoma
por: Sung, Pil Soo
Publicado: (2022)

Current Strategies for Modulating Tumor-Associated Macrophages with Biomaterials in Hepatocellular Carcinoma
por: Liu, Qiaoyun, et al.
Publicado: (2023)

Tumor markers for hepatocellular carcinoma
por: ZHAO, YAN-JIE, et al.
Publicado: (2013)

Preferential Expression of Programmed Death Ligand 1 Protein in Tumor-Associated Macrophages and Its Potential Role in Immunotherapy for Hepatocellular Carcinoma
por: Park, Dong-Jun, et al.
Publicado: (2021)

Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma
por: Lu, Jia-Cheng, et al.
Publicado: (2021)

Lower expressed miR-198 and its potential targets in hepatocellular carcinoma: a clinicopathological and in silico study
por: Huang, Wen-Ting, et al.
Publicado: (2016)

The Inflammatory Microenvironment in Hepatocellular Carcinoma: A Pivotal Role for Tumor-Associated Macrophages
por: Capece, Daria, et al.
Publicado: (2013)

Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma
por: Degroote, H., et al.
Publicado: (2018)

Single-Cell Transcriptomic Analysis Reveals Macrophage–Tumor Crosstalk in Hepatocellular Carcinoma
por: Liu, Yunhe, et al.
Publicado: (2022)

Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma
por: Li, Wenbin, et al.
Publicado: (2020)

Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection
por: Shu, Qing‐Hua, et al.
Publicado: (2016)

Unusual Ileocecal Ulcers after Liver Transplantation for Hepatitis B Cirrhosis and Hepatocellular Carcinoma
por: He, Kang, et al.
Publicado: (2022)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

Irreversible repolarization of tumour‐associated macrophages by low‐Pi stress inhibits the progression of hepatocellular carcinoma
por: Lv, Yang‐feng, et al.
Publicado: (2023)

The Clinical Significance of the CD163+ and CD68+ Macrophages in Patients with Hepatocellular Carcinoma
por: Kong, Ling-Qun, et al.
Publicado: (2013)

A phase I clinical trial utilizing autologous tumor-infiltrating lymphocytes in patients with primary hepatocellular carcinoma
por: Jiang, Shan-Shan, et al.
Publicado: (2015)

The Transcription of ZIP9 Is Associated With the Macrophage Polarization and the Pathogenesis of Hepatocellular Carcinoma
por: Gou, Yingying, et al.
Publicado: (2022)

CSF1R methylation is a key regulatory mechanism of tumor-associated macrophages in hepatocellular carcinoma
por: Cui, Bin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kmm1pjklm1j737rpoe2i0ou114